From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. STDs>
  4. Archives

STDs: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 476-500 of 509 are shown

Delay in HIV Treatment Bodes Ill in HCV-Coinfected Patients

A long interval between HIV diagnosis and initiation of potent combination antiretroviral therapy is associated with accelerated liver damage from HCV.

New Estimate of HIV/AIDS Epidemic in China

A new report, jointly released by the Chinese government, WHO, and UNAIDS, suggests that the number of HIV-infected people in China might be lower than . . .

High-Grade CIN: Risk Factors Above and Beyond HPV?

Associations between infection with oncogenic strains of human papillomavirus (HPV) and high-grade cervical intraepithelial neoplasia (CIN) are well documented. Less clear, however, are the roles . . .

A Single Pill for AIDS Nears Reality

The combination of tenofovir, FTC, and efavirenz might soon be available in a single pill.

Report from the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy

Originally planned for September in New Orleans, ICAAC 2005 was postponed and moved to Washington, DC, in December, right on the heels of the European . . .

Integrating Prevention into Routine Care

A clinician-delivered prevention strategy significantly reduced high-risk sexual behavior among HIV-infected patients.

Rapid Progression to Death in HIV/HCV-Coinfected Patients with End-Stage Liver Disease

HIV/HCV-coinfected patients with end-stage liver disease have poor survival rates, but potent combination antiretroviral therapy might help.

Validating a Resistance Score for Ritonavir-Boosted Atazanavir

In a small study of PI-experienced patients, the chances of virologic response to ritonavir-boosted atazanavir were greatest in those with fewer than three of eight identified mutations.

Androgen Deficiency in Older HIV-Infected Men

Certain comorbidities, including HCV seropositivity and injection drug use, are sometimes associated with low androgen levels in older HIV-infected men.

HIV Infection Might Predispose to Recurrent Malaria

In a large study from Uganda, HIV-infected adults (but not children) were unusually vulnerable to repeated episodes of malaria.

Package Insert Updated for Atazanavir

The FDA has approved a new package insert for atazanavir that includes new data on in vitro inhibition as well as information on the coadministration . . .

A Single Pill for AIDS Nears Reality

The combination of tenofovir, emtricitabine, and efavirenz might soon be available in a single pill.

Host Genetics, Risky Behaviors, and HIV Transmission

Who is — and who is not — susceptible to HIV, and why?

Advancing STD Detection by Use of Vaginal Swabs

Second-generation NAATs using vaginal-swab specimens provide high sensitivity and specificity in diagnosing <$EMPH_O>C. trachomatis<$EMPH_C> and <$EMPH_O>N. gonorrhoeae<$EMPH_C> infections.

RNA Interference Protects Against Genital Herpes in Mice

Whether this technology will work in human infection remains to be seen.

Enrollment Halted in the SMART Study

During a median follow-up of 24 months, patients who were interrupting therapy regularly had a higher risk for disease progression than did those who maintained continuous therapy.

Generic Antiretroviral Therapy Works Well in Haiti

Treatment-naive patients receiving generic NNRTI-based potent combination antiretroviral therapy in Haiti have had positive results similar to those seen in the U.S.

Nontuberculous Mycobacterial Immune Reconstitution Inflammatory Syndrome

Antimycobacterial therapy does not appear to improve symptoms associated with this syndrome, but most patients still have favorable outcomes.

The Generalizability (or Lack Thereof) of Trial Data

Because the exclusion criteria used in HIV treatment trials are often not fully reported, clinicians might incorrectly believe that the trial results are applicable to their patients.

TB Incidence Among HIV-Infected Patients Receiving Antiretrovirals in Developed Countries

TB risk is elevated among patients with a low CD4-cell count at the initiation of potent combination antiretroviral therapy and among those with a poor immunologic response to such therapy.

Another Triple-Nuke Regimen Goes Bust

Triple-NRTI therapy with tenofovir + 3TC/abacavir has an unacceptably high rate of rapid virologic failure and should not be used.

TB Meningitis: Higher Mortality in HIV-Positive Patients

In a cohort of Vietnamese patients with TB meningitis, HIV-positive patients had higher 9-month mortality rates than HIV-negative patients.

Less Than an Ounce of Prevention: Condoms Protect Against HSV-2

It makes intuitive sense that barrier methods of sexual protection used appropriately would prevent sexually transmitted diseases (STDs), including herpes simplex virus, but until now, . . .

PI Monotherapy as Maintenance HIV Treatment?

In a pilot clinical trial, lopinavir/ritonavir monotherapy effectively maintained HIV suppression.

Zinc Supplements Safe in HIV-Infected Children

Zinc supplementation is safe and effective in HIV-infected children and should be used in areas where zinc deficiency is common.

Items 476-500 of 509 are shown

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?





Copyright © 2009. Massachusetts Medical Society. All rights reserved.